© 2021 Osprey Medical Inc. All rights reserved.
Osprey Medical, DyeVert, DyeMINISH, and Be Kind to Kidneys are registered trademarks of Osprey Medical, Inc. in the United States and other countries.
At Osprey Medical, our mission is to improve outcomes in patients with Chronic Kidney Disease by reducing contrast induced Acute Kidney Injury (AKI) and lowering hospital costs. Osprey’s proprietary technologies reduce the amount of contrast (dye) injected into patients during heart catheterization procedures without compromising X-ray image quality for the physician.
Osprey’s DyeVert™ Contrast Reduction Systems provide a dye management delivery solution for both manual and automated power injection methods.
The DyeVert™ Plus EZ is compatible with manual-manifold injection systems, and the DyeVert™ Power XT is compatible with automated power injector systems.